Similarly, we observed a significant association with an increased risk of chronic GVHD in recipients with IL6-597 GG genotype compared with patients with the other genotypes (GG vs. GA vs. AA; P = 0.043; GG vs. GA/AA; P = 0.012; Fig. 4). This evidence concerns the gene IL6 and chronic graft versus host disease.